{"id":6680,"date":"2016-04-28T09:40:12","date_gmt":"2016-04-28T09:40:12","guid":{"rendered":"http:\/\/biomedpharmajournal.org\/?p=6680"},"modified":"2020-04-24T06:44:26","modified_gmt":"2020-04-24T06:44:26","slug":"numerical-simulation-of-the-impact-of-chorda-tendinea-rapture-on-the-mitral-valve-leaflets-stress-by-finite-element-method","status":"publish","type":"post","link":"https:\/\/biomedpharmajournal.org\/staging\/vol9no1\/numerical-simulation-of-the-impact-of-chorda-tendinea-rapture-on-the-mitral-valve-leaflets-stress-by-finite-element-method\/","title":{"rendered":"Numerical Simulation of The Impact of Chorda Tendinea Rapture on The Mitral Valve Leaflets Stress By Finite Element Method"},"content":{"rendered":"<p><strong>Introduction<\/strong><\/p>\n<p>Heart diseases is one of the most common death cause worldwide. [1] Simplifying of the heart geometry and tissues microstructure which are interacted with solids and fluids increase our knowledge of fluids dynamic in heart which is necessary for mechanical analysis of heart and surgeries. In fact, by imaging of the heart which can be done by removing the heart from the body, just high quality images would be obtained. Due to difference of the heart geometry inside and outside of the body, this would be a challenging issue. The next major obstacle in the prediction of the analysis is the lack of mechanical impact of heart valves. The sever impact of heart valves on fluid dynamic is obvious. [2]\n<p>The most important mechanical coupling which is between ventricle and heart valves caused by chorda tendinea which connect the free edges of front and rear leaflets to the muscles and thus to the left ventricle wall. [2, 3]\n<p>Leaking backward of blood is a clinical pathology involved the mitral valve and left ventricle with dynamic interaction between solids and fluids. Blood backflow to the left atrium in systole phase due to the changes in blood flow in heart and valves. This backflow causes lung swell and slight changes in the final volume left ventricular that is associated with mortality. [4] Modification of blood backflow to reduce myocardium tension and slow\/stop ventricular changes are the main goal of surgeries for this disorder. Numerical models of blood backflow and their modification are used to predict successful outcomes of surgeries to reduce tensions and improvement of blood flow. [2]\n<p>In general, a proper three-dimensional model will be needed for three-dimensional modeling and analysis of the mitral valve. The geometry of mitral valve was checked and entered to Catia software, after extracting of basic information from articles. The model was imported into the 3D finite element software (ADINA) and boundary condition was determined after specifying the valve properties and components, and finally the model was analyzed.[5] Extraction of stresses and strains were the outcome of this model analysis. [6]\n<p><strong>Methods<\/strong><\/p>\n<p><strong>Equations<\/strong><\/p>\n<p>The solid object equation is shown below. (Equation 1)<\/p>\n<p><img decoding=\"async\" class=\"alignnone size-full wp-image-6741\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_eqn1.jpg\" alt=\"Vol9_No1_has_num_eqn1\" width=\"374\" height=\"33\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_eqn1-300x26.jpg 300w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_eqn1.jpg 374w\" sizes=\"(max-width: 374px) 100vw, 374px\" \/><\/p>\n<p><strong>Equation 1 :Solid object equation. \u03c4: Tension, <em>f <\/em>\u00a0<em><sup>B<\/sup><\/em>: Physical force, \u03c1<sub>s<\/sub>: Density of solid object, \u00fc: Acceleration<\/strong><\/p>\n<p>Kinematics system should also be considered in order to achieve proper finite element form to apply solid model equation. A solid object with high mobility and low strain was assumed for the kinematics of this study model. Nonlinear dynamic equation (Equation 2) would be the most appropriate system to applying equations due to high mobility of assumed solid object. [7, 8]\n<p><img decoding=\"async\" class=\"alignnone size-full wp-image-6742\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_eqn2.jpg\" alt=\"Vol9_No1_has_num_eqn2\" width=\"461\" height=\"30\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_eqn2-300x20.jpg 300w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_eqn2.jpg 461w\" sizes=\"(max-width: 461px) 100vw, 461px\" \/><\/p>\n<p>Equation 2:\u00a0Nonlinear dynamic equation. <em>M<\/em>: Mass matrix, <em>C<\/em>: Dumping matrix, <em>K<\/em>: Stiffness matrix, R: External force vector, <em>F<\/em>: External force vector equal to the tension elements in the previous iteration, <em>\u00dc<\/em>: Acceleration of solid object nodes, : Speed of solid object nodes, <em>U<\/em>: Displacement of solid object nodes<\/p>\n<p>The <em>F<\/em> term in above equation was used to calculate nonlinear terms of the system. The <em>F<\/em> vector contains physical force, focused force, surface force, and primary stresses. M, C, and K matrices considered constant and shown in Equation 3.<\/p>\n<p><img decoding=\"async\" class=\"alignnone size-full wp-image-6743\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_eqn3.jpg\" alt=\"Vol9_No1_has_num_eqn3\" width=\"185\" height=\"221\" \/><\/p>\n<p>Equation 3- M, C, and K matrices. <em>i<\/em>: Element number. <em>\u03c1<\/em>: Elements\u2019 density, <em>k<\/em>: Elements\u2019 dumping activity coefficient, <em>H<\/em>: Element displacement element, <em>B<\/em>: Strain-displacement matrix of element, <em>C<\/em>: Elasticity matrix of element, <em>V<\/em>: Volume of element.<\/p>\n<p>There should be a special attention to degree of freedom when a solid object has been modeled. All rotational freedom degrees should be considered equal to zero to achieve convergence, if in a particular model only movement freedom degree taken into consideration. Suitable element should also selected for solid object to discretization of finite element method equations. When th boundary condition, material properties, element, and network applied correctly, solid model equations would be fully resolved. Newtonian method is used to linearize the system of equations and finally as fluid equations, solving sparse would be used for these liner system. [9]\n<p><strong>Numerical<\/strong> <strong>simulation<\/strong><\/p>\n<p>Valve geometry include annulus ring, leaflets, and tendons. Annulus would be investigated first. Annulus ring is roughly oval in shape.[10] Different models of valves are provided in various articles based on photos which are shown some of them in figure 1A. Although annulus ring is a dynamic part of heart valve, but a fixed geometry was assumed for it to reduce the complexity of this study\u2019s issue. An oval shape hole was considered for annulus profile. Figure 1B is a proposed annulus profile by Kevin Daniel Lau which is used in this study. \u00a0[11]\n<table style=\"width: 70%;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" class=\"alignnone size-thumbnail wp-image-6686\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig11-150x150.jpg\" alt=\"Figure 1: A) Various profiles for annulus. B) The annulus profile used in this study\" width=\"150\" height=\"150\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig11-150x150.jpg 150w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig11-256x256.jpg 256w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig11.jpg 649w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/td>\n<td><strong>Figure <\/strong><strong>1:<\/strong><strong>\u00a0A) Various profiles for annulus. B) The annulus profile used in this study<\/strong><\/p>\n<p><a href=\"http:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig11.jpg\" target=\"_blank\">Click here to View figure<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<p>The article of Emilliano Votta was also used to leaflets design. Leaflets can be considered as a surface with approximately 1mm thickness due to their inconsequential thickness. [12] Although there is disagreement about thickness of leaflets in various studies, but 1mm thickness is offered in all of them. The thickness of front and rear leaflets considered equal in this study which is corresponds to the reality with a little error. The form and angle of surfaces toward horizon of leaflets are shown in figure 2. The front leaflet is bigger than rear one but allocate smaller part of the annulus. This leaflet is monolithic. The rear leaflet consists three section and the middle one is bigger than others.<\/p>\n<table style=\"width: 70%;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td><a href=\"http:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig2.jpg\"><img decoding=\"async\" class=\"alignnone size-thumbnail wp-image-6688\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig2-150x150.jpg\" alt=\"Figure 2- A) Side view of valve. B) Dimensions of valve\" width=\"150\" height=\"150\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig2-150x150.jpg 150w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig2-256x256.jpg 256w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig2.jpg 628w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a><\/td>\n<td><strong>Figure <\/strong><strong>2:<\/strong><strong>\u00a0A) Side view of valve. B) Dimensions of valve<\/strong><\/p>\n<p><a href=\"http:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig2.jpg\" target=\"_blank\">Click here to View figure<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<p>The leaflet can be easily designed based on figure 2. Tendinous cords were also drawn as shown in this figure.<\/p>\n<p>Thus, the geometry of valve was designed on Catia software based on figure 2 and the sizes which are calculated in articles and prepared for finite element analysis. The resulting design is shown in figure 3.<\/p>\n<table style=\"width: 70%;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" class=\"alignnone size-thumbnail wp-image-6702\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig31-150x150.jpg\" alt=\"Figure 3: The geometry of leaflet based on Catia.\" width=\"150\" height=\"150\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig31-150x150.jpg 150w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig31.jpg 646w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/td>\n<td><strong>Figure <\/strong><strong>3:<\/strong><strong>\u00a0The geometry of leaflet based on Catia.<\/strong><\/p>\n<p><a href=\"http:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig31.jpg\" target=\"_blank\">Click here to View figure<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<p><strong>Mitral valve properties<\/strong><\/p>\n<p>Biomechanical behavioral measures of soft tissues require a carful definition of basic models which are need assessment of histologic and morphologic characteristics of desired tissue. Mechanical experimental tests face many operational problems. Therefore, numerical methods are easier way. Expert models which are associated with experimental data should be accepted considering to the nonlinear behavior of the materials.[13]\n<p>Heart valve tissue is soft and hydrated. Stress-strain responses are their macroscopic result of their microscopic structure. The tissue of valves\u2019 leaflets are formed by elastic matrix which are reinforced by collagen fibers. Tissues and their behaviors intended hyperelastic to analyze their large deformation. Hyperelastic materials have nonlinear stress-strain curve and large strains. Most of biologic tissues are hyperelastic.<\/p>\n<p>If the presence of strain energy density function could be assumed for an object, this material would be hyperelastic. Hyperelastic materials defined by energy function and also invariants of C matrix which is obtained from F transformation matrix. Strain energy function would be W=W(C), if proper amount of strain assumed. In this function, C is the right Cauchy Green tensor and C function is C=F<sup>T<\/sup>F which F in this equation is transformation gradient. According to these, stress-strain curve function is shown below.<\/p>\n<p><img decoding=\"async\" class=\"alignnone size-full wp-image-6735\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_eqn4.jpg\" alt=\"Vol9_No1_has_num_eqn4\" width=\"159\" height=\"35\" \/><\/p>\n<p>If the material being homogeneous, it can be shown that the strain energy function will be depend on C by their main invariables:<\/p>\n<p><img decoding=\"async\" class=\"alignnone size-full wp-image-6736\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_formula1.jpg\" alt=\"Vol9_No1_has_num_formula1\" width=\"486\" height=\"86\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_formula1-300x53.jpg 300w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_formula1.jpg 486w\" sizes=\"(max-width: 486px) 100vw, 486px\" \/><\/p>\n<p>Order structure of soft tissues, such as the presence of fibroids with specific space direction, determines the heterogeneous mechanical response of tissue. This fact can be calculated by checking the previous formula, the introduction of new invariants, which these invariants are directly related to the structure of tissue.<\/p>\n<p>For example, consider the presence of a fibers family in a particular direction in a small area of a tissue! Two more invariables will be introduced:<\/p>\n<p><img decoding=\"async\" class=\"alignnone size-full wp-image-6737\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_formula2.jpg\" alt=\"Vol9_No1_has_num_formula2\" width=\"257\" height=\"39\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_formula2-256x39.jpg 256w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_formula2.jpg 257w\" sizes=\"(max-width: 257px) 100vw, 257px\" \/><\/p>\n<p><em>A<\/em> is a unit vector that indicates the direction of fibers in no deformation state. The local direction of deformed state will be indicated by unit vector, a=FA\/\u03bb, which \u03bb represents the strain in fibers direction. The fourth invariable is square strain of tissue in fibers direction, while the fifth one will be calculated for the ratio of fibers to strain energy function which is depended on shear and direction of fibers. Thus, strain energy function and stress-strain equation will be equation 5.<\/p>\n<p><img decoding=\"async\" class=\"alignnone size-full wp-image-6738\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_eqn5.jpg\" alt=\"Vol9_No1_has_num_eqn5\" width=\"442\" height=\"97\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_eqn5-300x66.jpg 300w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_eqn5.jpg 442w\" sizes=\"(max-width: 442px) 100vw, 442px\" \/><\/p>\n<p>Basic model defined by the above equations are symmetrical and homogeneous, and usually use for many ideas and soft tissue mechanics. There is various models such as Ogden, Mooney-Rivlin, Polynomial, Reduced polynomial, Arruda-Boyce, Marlow Neo, and etc. for hyperelastic materials. A specific energy function is defined for all of these models and their coefficients will be determined.<\/p>\n<p>Moony-Rivlin hyperelastic 9 nominal model was used in this simulation for the first time. The model\u2019s W strain energy function is shown below.<\/p>\n<p><img decoding=\"async\" class=\"alignnone size-full wp-image-6739\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_formula3.jpg\" alt=\"Vol9_No1_has_num_formula3\" width=\"602\" height=\"56\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_formula3-300x28.jpg 300w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_formula3.jpg 602w\" sizes=\"(max-width: 602px) 100vw, 602px\" \/><\/p>\n<p>In this function, <em>I<sub>1<\/sub><\/em> and <em>I<sub>2<\/sub><\/em> are invariables of <em>C<sub>ii<\/sub><\/em> Cauchy Green deformation matrices:<\/p>\n<p><img decoding=\"async\" class=\"alignnone size-full wp-image-6740\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_formula4.jpg\" alt=\"Vol9_No1_has_num_formula4\" width=\"255\" height=\"45\" \/><\/p>\n<p>C1 to C9 are also constants of matter. These constants obtained from curve fitting to the experimental data of heart valves tissues stress-strain data which are reported by Yin and May- Newman [14] and given below.<\/p>\n<p>At first, the charts obtained from loading heart valves tissues is shown in figure 4. This graph is taken from Yin and May-Newman results of heart valves tissue tests.[15]\n<table style=\"width: 70%;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" class=\"alignnone size-thumbnail wp-image-6690\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig4-150x150.jpg\" alt=\"Figure 4: Stress-strain curve of valve tissue\" width=\"150\" height=\"150\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig4-150x150.jpg 150w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig4-256x256.jpg 256w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig4.jpg 426w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/td>\n<td><strong>Figure <\/strong><strong>4:<\/strong><strong>\u00a0Stress-strain curve of valve tissue<\/strong><\/p>\n<p><a href=\"http:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig4.jpg\" target=\"_blank\">Click here to View figure<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The graph and desired model coefficients are shown in figure 5 and table 1.<\/p>\n<p><strong>Table <\/strong><strong>1:<\/strong><strong>\u00a0Mooney-Rivlin Coefficients<\/strong><\/p>\n<table style=\"width: 95%;\" border=\"1\" cellspacing=\"0\" cellpadding=\"4\">\n<tbody>\n<tr>\n<td style=\"text-align: center;\"><strong>Variable<\/strong><\/td>\n<td style=\"text-align: center;\"><strong>Coefficients<\/strong><\/td>\n<td style=\"text-align: center;\"><strong>Variable<\/strong><\/td>\n<td style=\"text-align: center;\"><strong>Coefficients<\/strong><\/td>\n<td style=\"text-align: center;\"><strong>Variable<\/strong><\/td>\n<td style=\"text-align: center;\"><strong>Coefficients<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center;\"><strong>C1<\/strong><\/td>\n<td style=\"text-align: center;\">25517.1736493095<\/td>\n<td style=\"text-align: center;\">C4<\/td>\n<td style=\"text-align: center;\">10352.3090759319<\/td>\n<td style=\"text-align: center;\">C7<\/td>\n<td style=\"text-align: center;\">4376.38022869666<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center;\"><strong>C2<\/strong><\/td>\n<td style=\"text-align: center;\">19445.8910349734<\/td>\n<td style=\"text-align: center;\">C5<\/td>\n<td style=\"text-align: center;\">8151.7905945757<\/td>\n<td style=\"text-align: center;\">C8<\/td>\n<td style=\"text-align: center;\">3487.18987844141<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center;\"><strong>C3<\/strong><\/td>\n<td style=\"text-align: center;\">13126.1671986812<\/td>\n<td style=\"text-align: center;\">C6<\/td>\n<td style=\"text-align: center;\">5488.58097719279<\/td>\n<td style=\"text-align: center;\">C9<\/td>\n<td style=\"text-align: center;\">2776.6605548665<\/td>\n<\/tr>\n<tr>\n<td colspan=\"6\">The bulk modulus : 44963064.6842829<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<table style=\"width: 70%;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" class=\"alignnone size-thumbnail wp-image-6692\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig51-150x150.jpg\" alt=\"Figure 5- Stress-strain curve of used model\" width=\"150\" height=\"150\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig51-150x150.jpg 150w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig51-256x256.jpg 256w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig51.jpg 464w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/td>\n<td><strong>Figure <\/strong><strong>5:<\/strong><strong>\u00a0Stress-strain curve of used model<\/strong><\/p>\n<p><a href=\"http:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig51.jpg\" target=\"_blank\">Click here to View figure<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Due to high elasticity of tendons, they assumed elastic and linear. According to the paper by Votta, 16 Mpa and 0.45 were intended for Yang modulus and Poisson ratio of tendons. The model is elastic and isotropic. With these properties, desired model can be entered into the finite element software. ADINA ver. 8.8 was used for this study.<\/p>\n<p><strong>Uploading and boundary condition<\/strong><\/p>\n<p>Annulus ring was intended fix for boundary condition. Outer surfaces have systolic pressure and the inner ones have atrial pressure. Its diagram is shown in figure 6.<\/p>\n<table style=\"width: 70%;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" class=\"alignnone size-thumbnail wp-image-6693\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig6-150x150.jpg\" alt=\"Click here to View figure\" width=\"150\" height=\"150\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig6-150x150.jpg 150w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig6-256x256.jpg 256w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig6.jpg 494w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/td>\n<td><strong>Figure <\/strong><strong>6:<\/strong><strong>\u00a0Atrial and Ventricular pressure<\/strong><\/p>\n<p><a href=\"http:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig6.jpg\" target=\"_blank\">Click here to View figure<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The used elements were triangular. Settings were intended for large deformation and convergence of the subject. The number of steps were 8022 and the minimum E-4 time step was 1.24667581. The total time for solving was 8245.47s (\u2248 2.5 hours). The number of triangular elements were 46210. The valve shape before analysis is shown in figure 7<\/p>\n<table style=\"width: 70%;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" class=\"alignnone size-thumbnail wp-image-6694\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig7-150x150.jpg\" alt=\"Figure 7- The finite element model of valve\" width=\"150\" height=\"150\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig7-150x150.jpg 150w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig7-256x256.jpg 256w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig7.jpg 470w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/td>\n<td><strong>Figure <\/strong><strong>7<\/strong><strong>&#8211;<\/strong><strong> The finite element model of valve<\/strong><\/p>\n<p><a href=\"http:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig7.jpg\" target=\"_blank\">Click here to View figure<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<p><strong>Results and Discussion<\/strong><\/p>\n<p>First, the valve function was analyzed in normal mode. The results showed normal function of valve in this mode, according to the physiologic boundary condition. Stresses and strains of valve were derived on various times conditions in the analysis. Analyzing the normal function of valve can be used as a standard for comparison of its operation in healthy and damaged mode of valve. [16]\n<p><strong>Mitral valve performance analysis<\/strong><\/p>\n<p>As it shown in figure 8, primary tension is significantly high near the annulus and it increases by the time. With closure of the mitral valve, sever tension will be observed in parts of leaflets which are near the annulus. There is also sever strains in these parts.<\/p>\n<table style=\"width: 70%;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" class=\"alignnone size-thumbnail wp-image-6695\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig8-150x150.jpg\" alt=\"Figure 8: The maximum of shear stress for normal valve in various times. A) t= 0.6s, B) t= 0.8s, and C) t= 1s\" width=\"150\" height=\"150\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig8-150x150.jpg 150w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig8-256x256.jpg 256w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig8.jpg 682w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/td>\n<td><strong>Figure <\/strong><strong>8:<\/strong><strong>\u00a0The maximum of shear stress for normal valve in various times. A) t= 0.6s, B) t= 0.8s, and C) t= 1s<\/strong><\/p>\n<p><a href=\"http:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig8.jpg\" target=\"_blank\">Click here to View figure<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<p>The reason of this phenomenon is clear. A sever tension inserted to the high deformable tissue of valve and therefore the leaflets next to the annulus will be severely deformed. Valves\u2019 strain in various times are shown in figure 9<\/p>\n<table style=\"width: 70%;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" class=\"alignnone size-thumbnail wp-image-6696\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig9-150x150.jpg\" alt=\"Figure 9: Logarithmic strain of normal valve in various times. A) t=0.6s and B) t=1s\" width=\"150\" height=\"150\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig9-150x150.jpg 150w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig9-256x256.jpg 256w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig9.jpg 663w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/td>\n<td><strong>Figure <\/strong><strong>9:<\/strong><strong>\u00a0Logarithmic strain of normal valve in various times. A) t=0.6s and B) t=1s<\/strong><\/p>\n<p><a href=\"http:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig9.jpg\" target=\"_blank\">Click here to View figure<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<p>After rising the tension in these regions, the tension is severely reduced in free edges of valve which was expected.<\/p>\n<p>Another important point in this analysis is the tension in chorda tendinea and connection point of them to the leaflets. The beneficial and important role of these chorda tendinea in proper form of valve to have acceptable and accurate closure can be observed in figure 8 and 9. It is notable that the tension in chorda tendinea is so much lower than valve. Chorda tendinea will have lower deformity rather than valve due to higher elasticity of their tissue than valve tissue.<\/p>\n<p><strong>Valve performance analysis in rupture mode (Prolapse) <\/strong><\/p>\n<p>In next step, as it said before, the valve performance was analyzed in rupture mode. For this, some tendons assumed damaged. The results showed different tension in leaflets and chorda tendinea. Figure 10 shows the effect of tension on damaged valve and the chorda tendinea response is shown in figure 11. The simulation was done by ADINA software.<\/p>\n<table style=\"width: 70%;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" class=\"alignnone size-thumbnail wp-image-6697\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig10-150x150.jpg\" alt=\"Figure 10: Effective tension on prolapse mode in various times. A) t=0.2s, B) t=0.6s, C) t=0.8s, and D) t=1s\" width=\"150\" height=\"150\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig10-150x150.jpg 150w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig10-256x256.jpg 256w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig10.jpg 650w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/td>\n<td><strong>Figure <\/strong><strong>10:<\/strong><strong>\u00a0Effective tension on prolapse mode in various times. A) t=0.2s, B) t=0.6s, C) t=0.8s, and D) t=1s<\/strong><\/p>\n<p><a href=\"http:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig10.jpg\" target=\"_blank\">Click here to View figure<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<table style=\"width: 70%;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" class=\"alignnone size-thumbnail wp-image-6698\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig111-150x150.jpg\" alt=\"Figure 11: The effective tension on chorda tendinea in prolapse mode after 1sec.\" width=\"150\" height=\"150\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig111-150x150.jpg 150w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig111-256x256.jpg 256w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig111.jpg 600w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/td>\n<td><strong>Figure <\/strong><strong>11:<\/strong><strong>\u00a0The effective tension on chorda tendinea in prolapse mode after 1sec.<\/strong><\/p>\n<p><a href=\"http:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2016\/03\/Vol9_No1_has_num_fig111.jpg\" target=\"_blank\">Click here to View figure<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<p><strong>Valve performance analysis in rupture mode (Prolapse)<\/strong><\/p>\n<p>In next step, as it said before, the valve performance was analyzed in rupture mode. For this, some tendons assumed damaged. The results showed different tension in leaflets and chorda tendinea. Figure 10 shows the effect of tension on damaged valve and the chorda tendinea response is shown in figure 11. The simulation was done by ADINA software.<\/p>\n<p><strong>Conclusion<\/strong><\/p>\n<p>This method can show the position of leaflets with high tension, so this method would be a powerful measuring tool for physicians, during or prior of surgery, to show critical location of leaflets for focusing during the surgery. It will be expected that most experienced physicians would be have more successful surgery by using this method.<\/p>\n<p><strong>References<\/strong><\/p>\n<ol>\n<li>A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, W.B. Borden, D.M. Bravata, S. Dai, E.S. Ford, C.S. Fox, Heart disease and stroke statistics&#8211;2013 update: a report from the American Heart Association. Circulation 127 (2013) e6.<\/li>\n<li>\u00a0D.R. Einstein, F. Del Pin, X. Jiao, A.P. Kuprat, J.P. Carson, K.S. Kunzelman, R.P. Cochran, J.M. Guccione, M.B. Ratcliffe, Fluid\u2013structure interactions of the mitral valve and left heart: comprehensive strategies, past, present and future. International Journal for Numerical Methods in Biomedical Engineering 26 (2010) 348-380.<\/li>\n<li>\u00a0H. Muresian, The clinical anatomy of the mitral valve. Clinical anatomy 22 (2009) 85-98.<\/li>\n<li>\u00a0L.A. Pi\u00e9rard, P. Lancellotti, The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. New England Journal of Medicine 351 (2004) 1627-1634.<\/li>\n<li>K. Kunzelman, R. Cochran, C. Chuong, W. Ring, E. Verrier, R. Eberhart, Finite element analysis of the mitral valve. The Journal of heart valve disease 2 (1993) 326-340.<\/li>\n<li>H. Zhang, X. Zhang, S. Ji, Y. Guo, G. Ledezma, N. Elabbasi, Recent development of fluid\u2013structure interaction capabilities in the ADINA system. Computers &amp; structures 81 (2003) 1071-1085<\/li>\n<li>\u00a0M. Stevanella, E. Votta, A. Redaelli, Mitral valve finite element modeling: implications of tissues\u2019 nonlinear response and annular motion. Journal of biomechanical engineering 131 (2009) 121010.<\/li>\n<li>T. Mansi, I. Voigt, B. Georgescu, X. Zheng, E.A. Mengue, M. Hackl, R.I. Ionasec, T. Noack, J. Seeburger, D. Comaniciu, An integrated framework for finite-element modeling of mitral valve biomechanics from medical images: application to MitralClip intervention planning. Medical image analysis 16 (2012) 1330-1346.<\/li>\n<li>K. Bathe, Theory and Modeling Guide, Vol III: ADINA-F, ADINA R&amp;D. Inc, Watertown, MA (2003).<\/li>\n<li>V. Prot, R. Haaverstad, B. Skallerud, Finite element analysis of the mitral apparatus: annulus shape effect and chordal force distribution. Biomechanics and modeling in mechanobiology 8 (2009) 43-55.<\/li>\n<li>K. Lau, V. Diaz, P. Scambler, G. Burriesci, Mitral valve dynamics in structural and fluid\u2013structure interaction models. Medical engineering &amp; physics 32 (2010) 1057-1064.<\/li>\n<li>E. Votta, E. Caiani, F. Veronesi, M. Soncini, F.M. Montevecchi, A. Redaelli, Mitral valve finite-element modelling from ultrasound data: a pilot study for a new approach to understand mitral function and clinical scenarios. Philosophical Transactions of the Royal Society of London A: Mathematical, Physical and Engineering Sciences 366 (2008) 3411-3434.<\/li>\n<li>V. Prot, B. Skallerud, Nonlinear solid finite element analysis of mitral valves with heterogeneous leaflet layers. Computational Mechanics 43 (2009) 353-368.<\/li>\n<li>K. May-Newman, F. Yin, Biaxial mechanical behavior of excised porcine mitral valve leaflets. American Journal of Physiology-Heart and Circulatory Physiology 269 (1995) H1319-H1327.<\/li>\n<li>K. May-Newman, F. Yin, A constitutive law for mitral valve tissue. Journal of biomechanical engineering 120 (1998) 38-47.<\/li>\n<li>E. Yellin, S. Laniado, C. Peskin, R. Frater, Analysis and interpretation of the normal mitral valve flow curve. The mitral valve (1976) 163-172.<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Introduction Heart diseases is one of the most common death  [&#8230;]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[],"class_list":["post-6680","post","type-post","status-publish","format-standard","hentry","category-vol9no1"],"_links":{"self":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/6680","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/comments?post=6680"}],"version-history":[{"count":5,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/6680\/revisions"}],"predecessor-version":[{"id":32630,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/6680\/revisions\/32630"}],"wp:attachment":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/media?parent=6680"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/categories?post=6680"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/tags?post=6680"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}